NIH-funded research R01 grant

How the Mediterranean diet affects aging and disease progression in multiple sclerosis

Official title: Mediterranean Diet, Biological Aging, and Risk for Disease and Disability Progression in Multiple Sclerosis

Funded at Icahn School of Medicine at Mount Sinai · NIH-10993138 · Data updated 2026-11-12

This study is looking at how following the Mediterranean diet might help slow down aging and improve brain health for people with multiple sclerosis (MS), by checking if their eating habits can make a difference in their overall health and how their condition progresses.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startDecember 1, 2023
Project endNovember 30, 2027
Funding year2025
Award (this year)$379,197
NIH project number5R01NS135228-02
Project IDNIH-10993138 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with multiple sclerosis who are interested in dietary changes and their potential effects on their condition.

Less likely to help

Patients with multiple sclerosis who are not open to dietary changes or who have contraindications to the Mediterranean diet may not benefit from this research.

What this research studies

This research investigates the impact of the Mediterranean diet on biological aging and its potential role in slowing down neurodegeneration and functional decline in individuals with multiple sclerosis (MS). By analyzing data from two existing cohorts, the study aims to understand how dietary habits may influence biological aging markers and, in turn, affect disease progression. The research will utilize advanced methodologies, including the National Health and Nutrition Examination Survey Biological Aging Index and leukocyte telomere length measurements, to explore these relationships. Patients with MS will be monitored for changes in brain health and functional outcomes as they adhere to the Mediterranean diet.

Why it matters

Potential benefit: If successful, this research could provide insights into dietary interventions that may help slow the progression of multiple sclerosis and improve quality of life for patients.

How similar studies have gone: Previous research has shown promising results linking the Mediterranean diet to improved health outcomes in various populations, suggesting potential for success in this study as well.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Katz Sand, Ilana Beth — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Katz Sand, Ilana Beth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.